Vitamin c and chemo combo tested in Hard-to-Treat myeloma
Disease control
Completed
This early-phase study tested a combination of high dose vitamin C and a low dose of the chemotherapy drug melphalan in 6 patients with multiple myeloma that had stopped responding to other treatments. The main goal was to check safety, and researchers also looked for signs that …
Phase: PHASE1 • Sponsor: Christopher Strouse • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC